C-Peptide and Its Fragments Help Red Blood Cells in Type 1 Diabetes
Author Information
Author(s): Thomas Hach, Thomas Forst, Thomas Kunt, Karin Ekberg, Andreas Pfützner, John Wahren
Primary Institution: University of Mainz
Hypothesis
This study aimed to investigate the influence of C-peptide and fragments thereof on erythrocyte deformability and to elucidate the relevant signal transduction pathway.
Conclusion
C-peptide and its C-terminal fragments are equally effective in improving erythrocyte deformability in type 1 diabetes.
Supporting Evidence
- Erythrocyte deformability was impaired by 18–25% in type 1 diabetic patients compared to matched controls.
- C-peptide, penta- and hexapeptide all significantly improved the impaired erythrocyte deformability of type 1 diabetic patients.
- The middle fragment and scrambled C-peptide had no detectable effect on erythrocyte deformability.
- Treatment with ouabain or EDTA completely abolished the C-peptide effects.
Takeaway
C-peptide and its pieces can help red blood cells move better in people with type 1 diabetes, making it easier for blood to flow.
Methodology
Blood samples from 23 patients with type 1 diabetes and 15 matched healthy controls were incubated with various C-peptide fragments, and erythrocyte deformability was measured using laser diffractoscopy.
Limitations
The study did not evaluate the influence of G-protein inactivation on the effects mediated by C-peptide and its fragments.
Participant Demographics
23 type 1 diabetes patients (13 male, 10 female) and 15 healthy controls (8 male, 7 female), aged approximately 34-36 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website